The novel therapy of this peptide represents a exciting breakthrough in the care of type 2 diabetes. Distinct from existing medications, tirzepatide affects two pathways – GLP-1 and the GIP hormone – leading to https://tirzepatide-peptide413123.digitollblog.com/42010443/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment